Concepedia

Heidi Whalen

HW

9

Publications

696

Citations

9

H-Index

2009

Active since

Affiliations

Synthetic Biologics (United States)(Current)

University of Pennsylvania

Heidi Whalen is an author at Synthetic Biologics (United States) specializing in bacterial pathogens, clinical microbiology, and antibiotics.

Top concepts

Publications per year

2009–2025

9

Publications

9

Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder

Karl Rickels, Donald S. Robinson, Michael Gibertini et al. · The Journal of Clinical Psychiatry · 2009 · 143 citations

A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder

Arif Khan, Andrew J. Cutler, Daniel K. Kajdasz et al. · The Journal of Clinical Psychiatry · 2011 · 131 citations

Candidate Gene Analysis Identifies a Polymorphism in<i>HLA-DQB1</i>Associated With Clozapine-Induced Agranulocytosis

Michael Dettling, Ingolf Cascorbi, Igor Mosyagin et al. · The Journal of Clinical Psychiatry · 2010 · 129 citations

Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial

John F. Kokai‐Kun, Tracey Roberts, Olivia Coughlin et al. · The Lancet Infectious Diseases · 2019 · 82 citations

, , +11

A 1-Year, Open-Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder

Donald S. Robinson, Daniel K. Kajdasz, Susan Gallipoli et al. · Journal of Clinical Psychopharmacology · 2011 · 81 citations

Rows per page

1–5 of 9